Successful healthcare systems like Kaiser improve blood pressure control not through better individual doctors, but by implementing system-wide solutions: standardized treatment protocols, empowered care teams, and actionable data registries. This shifts the focus from individual effort to scalable processes.

TrueMed's model allows consumers to use tax-free HSA/FSA funds for preventative health measures like gym memberships and healthy food. By facilitating a "letter of medical necessity," it effectively reclassifies these lifestyle interventions as legitimate medical expenses, creating a financial incentive for prevention.

While fee-for-service models incentivize in-clinic treatments, value-based care shifts the focus to outcomes and overall cost. Under these new models, home dialysis—which offers better patient outcomes and lower societal costs—becomes more profitable for providers, creating a powerful financial incentive to drive adoption.

General Catalyst's CEO highlights a core flaw in healthcare: insurance providers don't reimburse for longevity or preventative care because customers frequently switch plans, preventing insurers from capturing long-term ROI. The first company to solve this misalignment and make longevity "financeable" will unlock a massive market.

Current healthcare is a 'sick care' system that reacts to problems after they arise. AI health agents, by continuously integrating data from wearables, environment, and even smart appliances, can identify baseline health and prompt proactive behaviors to optimize wellness and prevent disease from occurring.

The future business model for health tech will shift from subscriptions (SaaS) to outcomes. Vendors will be paid based on the tangible results they generate, such as cost savings or improved patient health, aligning incentives.

A $2,000 preventative injection like a PCSK9 inhibitor sounds expensive. However, its cost is likely justified when calculated against the massive societal and individual expense of future medical bills, plus the economic value of additional healthy, productive years.

To ensure universal focus on a key clinical outcome, healthcare company Alidaid links 20% of its corporate bonus pool to patient blood pressure control rates. This financially aligns every employee, from executives to engineers, with the primary mission of improving patient health, creating a powerful incentive for focus and collaboration.

For life sciences startups, UPMC's model shows that an integrated payer-provider views expensive therapies not just as a line-item cost but as a potential long-term saving. They calculate value based on reducing other system costs like hospital stays, supplemental drugs, or future procedures.